Spotlight on Methods - Webinars of the European Cochrane Groups

Spotlight on Methods – Webinars of the European Cochrane Groups

In these one-hour live webinars, experts present selected topics on methods for producing and using evidence syntheses, with a focus on new approaches and recent developments. Each webinar is organised by a different European Cochrane Group. The series also provides a forum for discussing current methodological challenges in review work and exchanging ideas.

  • Participation is free of charge.
  • We use Zoom – further information on its use can be found here.
  • Registration is required.

Don’t miss any more webinar dates!
To receive updates on future webinar dates, join the mailing list for events organised by Cochrane Germany and select Spotlight on Methods – Webinars of the European Cochrane Groups. We will notify you as soon as registration opens.


  • 18th November, 14:00-15:00 CET
Topic: Use of QUADAS-3 for quality assessment of Diagnostic test accuracy studies in evidence synthesis

Diagnostic test accuracy (DTA) studies may have shortcomings in their design and conduct that may bias their results. QUADAS-2, published in 2011, is the most widely used tool for assessing the risk of bias and applicability in this type of study. QUADAS-3 is the next iteration of this tool and contains several improvements to the previous version. Risk of bias and applicability are now assessed at the estimate level (rather than the study level), and are assessed in relation to an 'ideal test accuracy trial'. The tool largely retains the 4 domain structure, now named Participants, Index Test, Target Condition, and Analysis, with several new and updated signaling questions. Users can furthermore make an overall judgement of risk of bias (and applicability), across these four domains.

Speaker: Bada Yang, Biomarker and Test Evaluation (BiTE) group, Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, The Netherlands
 

Registration

 

  • 16th December, 14:30-15:30 CET

Topic: Using automation to support the assessment of the methodological quality of the systematic reviews

In this webinar, we will be presenting an approach to use artificial intelligence to support the assessment of the reported methodological quality of systematic reviews. In particular, we will introduce ReMarQ, a quality assessment tool that has been designed with the purpose of being potentially implemented by a large language model (LLMs). We will discuss the implementation of ReMarQ using LLMs both in terms of methodological development and practical applications (e.g., in guideline development or in meta-research projects).

Speaker: Bernardo Sousa-Pinto (MD, PhD), Assistant Professor at the Faculty of Medicine of the University of Porto, MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences

Host: Cochrane Croatia

Registration

 

  • 27th January, 14:30-15:30 CET

Topic: Retrospective Evaluation of Artificial Intelligence-supported Tools for Systematic Literature Searching

Speaker: Irma Klerings (Universität für Weiterbildung Krems),  Dr. Corinna Dressler (Charité - Universitätsmedizin Berlin)

Host: Cochrane Austria

Registration

 

  • 16th February, 13:00-14:00 CET

Topic: Adaptive trials: What are they, and which implications for systematic reviews?

Speaker: Dr Chris Rose (Norwegian Institute of Public Health)

Host: Cochrane Sweden

Registration

 

  • 17th March, 14:30-15:30 CEST

Topic: TACIT (Tool for Addressing Conflicts of Interest in Trials) for use in systematic reviews

Clinical trials are often funded by commercial companies and include investigators with financial ties to these companies. Previously, there has been little guidance on how to address such conflicts of interest when conducting systematic reviews. The Tool for Addressing Conflicts of Interest in Trials (TACIT) provides systematic reviewers with a framework for addressing conflicts of interest in trials included in Cochrane Reviews and other systematic reviews. This webinar will outline the development and practical use of TACIT. 

Speaker: Associate professor Andreas Lundh (Cochrane Denmark and Centre for Evidence-based Medicine Odense at University of Southern Denmark)

Host: Cochrane Denmark

Registration

 

  • 13th April, 14:00-15:00 CEST

Topic: Selecting and reporting outcomes in Cochrane reviews

Selecting and reporting outcomes is central to producing Cochrane reviews that are focused and relevant to decision-makers. This webinar will share practical guidance for review authors on selecting, prioritising, and reporting outcomes, drawing on existing guidance, training resources, and peer review expectations. We will explore common questions and challenges that arise during outcome selection and reporting and create space for discussion, allowing authors to share their experiences and identify where additional guidance, training, or resources may be helpful. 

Speaker: Jo-Ana Chase, Emma Axon, Clare Miles (Cochrane Central)

Host: Cochrane Sweden

Registration


Missed a webinar?

Cochrane Germany: Emma France & Jane Noyes "Preview of the new PRISMA-QES reporting guideline for qualitative evidence synthesis" (28th October 2026)

Cochrane Norway & Cochrane Sweden: Prof. Zachary Munn "Addressing confusion across the different types of the evidence synthesis: Introducing the Evidence Synthesis Taxonomy Initiative" (1st September 2026)

Cochrane France: Sally Yaacoub, BS Pharm, MPH, PhD, "Trustworthiness beyond traditional bias domains" (10th June 2026)

Cochrane Norway: Dr. Ingrid Töws, "Non-dissemination and dissemination bias 
in qualitative research" (20th May 2026)

Cochrane Italy: Silvia Minozzi, MD, MSc & Francesco Nonino, MD, MSc, "Assessing the Certainty of the Evidence by Means of Absolute Estimates of Effect: the New GRADE Approach" (21st April 2026)

Cochrane Austria: Prof. Dr. Matthias Briel, "Risk of bias assessment using ROBUST-RCT" (18th March 2026)

Cochrane Ireland: Dr. Jack Wilkinson, "Too good to be true – Spotting problematic trials in systematic reviews" (26th February 2026)